Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
Merkies
Ingemar S J
IS
Department of Neurology, Spaarne Hospital, Hoofddorp, The Netherlands. imerkies@spaarneziekenhuis.nl
Hughes
Richard A C
RA
Donofrio
Peter
P
Bril
Vera
V
Dalakas
Marinos C
MC
Hanna
Kim
K
Hartung
Hans-Peter
HP
Latov
Norman
N
van Doorn
Pieter A
PA
Deng
Chunqin
C
D004185:Disability Evaluation; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D018737:Hand Strength / Q000502:physiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D009431:Neural Conduction / Q000502:physiology; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000276:immunology / Q000503:physiopathology / Q000523:psychology* / Q000628:therapy*; D011788:Quality of Life; D012044:Regression Analysis; D012189:Retrospective Studies; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous